News

The latest news for pharma industry insiders.

A study investigates how a New Mexico law can impact patients’ out-of-pocket costs surrounding mental health and substance use disorder medications.

The latest news for pharma industry insiders.

The new option will help patients receive life-saving medications at an even quicker rate.

A study of patients with the long-term conditions who are required to switch to high-deductible health plans could potentially be more likely to experience diabetes complications than those who stay in standard insurance plans.

The latest news for pharma industry insiders.

In an interview with Pharma Commerce Associate Editor Don Tracy, Adrianna Nava, PhD, MPA, MSN, RN, President, National Association of Hispanic Nurses (NAHN) talks about the organization's mission and goals.

The organizations conducted an in-depth study of the program over the course of two years, publishing a white paper on the findings.

The latest news for pharma industry insiders.

The purpose for the deal, the CDMO says, is to meet the demand for commercial mammalian contract manufacturing.

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, The PAN Foundation discusses the overall mission of the organization.

The latest news for pharma industry insiders.

A multiple myeloma survivor shares his story, including how patient assistance made a positive impact.

Presentation discusses the evolution of the patient assistance landscape, while presenting ways to collaborate.

In an interview with Pharma Commerce Associate Editor Don Tracy, Tiara Green, Interim CEO, Accessia Health offers insight on challenges faced by patient assistance organizations and how to face them.

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC offers his thoughts on the Inflation Reduction Act and discusses current advocacy efforts.

The latest news for pharma industry insiders.

Presentation offers insight on this aforementioned model that assists retail and specialty-lite brands.

In an interview with Pharma Commerce Associate Editor Don Tracy, Amy Niles, Chief Mission Officer, PAN Foundation offers her thoughts on the session and feedback from the audience at PAP 2024 in Philadelphia.

Fireside chat uncovers ways to leverage this technology in order to boost medication adherence, engagement, and outcomes.

In an interview with Pharma Commerce Associate Editor Don Tracy, Monique French, MPH, Senior Director, Patient Advocacy, Health Policy & Communications, Rx4Good provides insight on engaging multiple healthcare groups.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the important and often missing element in strategic planning for clinical-stage companies—and ways to close that focus gap.

The latest news for pharma industry insiders.

In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.

In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC talks about his 'Health Equity Spotlight' panel and advocacy accomplishments.

Conference’s opening session addresses the evolving landscape of healthcare coverage and accessibility.

The FDA previously granted priority review to a biologics license application for V116 as a single dose for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, talks about the challenging environment today for emerging biopharma companies in demonstrating the value of their promising early-stage drug candidates to potential investors or buyers.

The latest news for pharma industry insiders.